Secondary tumors of the ovary account for 10–25% of all ovarian malignancies. The most
common tumors that give rise to ovarian metastases include breast, colorectal, endometrial …

Immunohistochemistry represents an indispensable complement to an epidemiology and
morphology-driven approach to tumor diagnosis and site of origin assignment. This review …

Mucinous ovarian carcinomas (MCs) typically do not respond to current conventional
therapy. We have previously demonstrated amplification of HER2 in 6 of 33 (18.2%) …

Background Mucinous ovarian tumors represent a distinct histotype of epithelial ovarian
cancer. The rarest (2-4% of ovarian carcinomas) of the five major histotypes, their genomic …

The pathologic approach to metastases of unknown primary cancer (UPC) is stepwise and
uses the clinical context, morphology, and, where necessary, immunohistochemistry (IHC) …

The primary origin of some ovarian mucinous tumors may be challenging to determine,
because some metastases of extraovarian origin may exhibit gross, microscopic, and …

BACKGROUND: Primary mucinous adenocarcinomas of the ovary are uncommon, and their
biological behavior is uncertain. Retrospective studies have suggested that many mucinous …

Mucinous carcinomas are uncommon histological types that affect several organ sites.
Primary mucinous carcinomas of the ovary are distinct from other ovarian carcinoma types …

Mucinous neoplasms of the ovary account for 10%–15% of ovarian neoplasms. They may
be benign, borderline, or malignant. The large majority are benign or borderline, accounting …

Genome-wide association studies have identified several risk associations for ovarian
carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC …